November 13, 2014 Press release Mitsubishi Tanabe Pharma Corporation Application filed for additional indication for ALS for RADICUT® inj. 30mg and RADICUT® BAG for I.V. Infusion 30mg - Indication - Document - PDFSEARCH.IO

First Page	Meta Content
	November 13, 2014 Press release Mitsubishi Tanabe Pharma Corporation Application filed for additional indication for ALS for RADICUT® inj. 30mg and RADICUT® BAG for I.V. Infusion 30mg Add to Reading List Document Date: 2014-11-12 20:30:33 Open Document File Size: 84,91 KB Share Result on Facebook City Osaka / / Company Mitsubishi Tanabe Pharma Corporation / / Country Japan / / Event FDA Phase / / IndustryTerm manufacturing / / MedicalCondition cerebral infarction / muscular atrophy / progressive and intractable disease / ALS / Amyotrophic Lateral Sclerosis / / Organization Corporate Communications Department / / Person Masayuki Mitsuka / / / Position Director / CEO / President & Representative / / Product RADICUT® BAG / BAG / / SocialTag Mitsubishi companies Economy of Asia Mitsubishi Amyotrophic lateral sclerosis Economy of Japan

November 13, 2014 Press release Mitsubishi Tanabe Pharma Corporation Application filed for additional indication for ALS for RADICUT® inj. 30mg and RADICUT® BAG for I.V. Infusion 30mgAdd to Reading List